The toxicity of soluble oligomers is a trigger for neurodegenerative disorders such as AD and Parkinson’s disease although, by targeting distinct species of Aβ and tau for therapeutic intervention, there is currently no effective way to completely cure these diseases [57,58]. This evidence concerns the gene MAPT and Parkinson disease.